Recombinant Human KDR /VEGFR2 Protein
Recombinant Human KDR /VEGFR2 Protein (RP02101-GRP)
Products
Description
Recombinant Human KDR /VEGFR2 Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Ala20-Glu764) of Human KDR /VEGFR2 fused with a His and Avi tag at the C-terminal.
Specifications
| Manufacturer | Abclonal Biotechnology |
|---|---|
| Manufacturer Cat# | RP02101 |
| Bio-Activity | Immobilized Human VEGFR2,His Tag at 0.5ug/ml (100ul/Well). Dose response curve for Anti-VEGFR2 Ab. with the EC50 of 36.9ng/ml determined by ELISA. |
| Alternate Names | CD309 antigen, CD309, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, Flk1, Flk-1, FLK1tyrosine kinase growth factor receptor, KDR, kinase insert domain receptor (a type III receptor tyrosine kinase), Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGF R2, VEGFR, VEGFR2, VEGFR-21 |
| Reactivity | Human |
| Gene ID | 3791 |
| Swiss Prot | P35968 |